Why is Sanofi India falling/rising?

As of 17-Sep, Sanofi India Ltd's stock price is currently at 5,060.75, reflecting an increase of 31.3 or 0.62%. The stock has shown a trend reversal, gaining after three consecutive days of decline, and has outperformed its sector by 0.58% today. Despite this positive movement, the stock has underperformed in the longer term, with a year-to-date decline of 17.03% and a one-year return of -29.30%. The company has a high management efficiency with a return on equity (ROE) of 35.83% and a low debt-to-equity ratio, which are positive indicators. However, it is trading at a premium compared to its peers, and its profits have decreased by 10% over the past year, contributing to a cautious outlook.
In the broader market context, the stock's short-term performance contrasts with the Sensex, which has increased by 1.56% over the past week and 2.60% over the past month. This indicates that while Sanofi India has seen a slight uptick today, it continues to lag behind the overall market trends. The stock's long-term growth prospects are concerning, with net sales and operating profit declining over the last five years, and recent quarterly results showing significant drops in profit before tax and profit after tax compared to previous averages. This combination of factors suggests that while there may be short-term gains, the overall sentiment remains cautious due to the company's poor long-term growth trajectory.